Trial Profile

A Double-Blind, Placebo-Controlled, Three-Panel Trial Investigating Safety, Tolerability and Pharmacokinetics of MK-8591 in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Apr 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Islatravir (Primary)
Indications HIV-1 infections; HIV-2 infections
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

18 Apr 2018 New trial record
07 Mar 2018 Results of pharmacokinetic analysis and the relationship of these data with data from the antiviral efficacy trial in HIV-1 infected subjects, presented at the 25th Conference on Retroviruses and Opportunistic Infections.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com